J&J/Cordis Previews Cypher Cost Benefit Data, Presses Cath Lab Savings

The cost-effectiveness ratio for using Johnson & Johnson/Cordis' Cypher sirolimus-eluting stent is approximately $5,471 at nine months to one year compared with bare metal stents, according to data to be presented to the American College of Cardiology in March